Connection

MALCOLM BRENNER to Hematopoietic Stem Cells

This is a "connection" page, showing publications MALCOLM BRENNER has written about Hematopoietic Stem Cells.
Connection Strength

1.952
  1. Gene-marking studies of hematopoietic cells. Int J Hematol. 2001 Jan; 73(1):14-22.
    View in: PubMed
    Score: 0.135
  2. To be or notch to be. Nat Med. 2000 Nov; 6(11):1210-1.
    View in: PubMed
    Score: 0.133
  3. A novel herpes vector for the high-efficiency transduction of normal and malignant human hematopoietic cells. Blood. 1997 Jan 01; 89(1):119-27.
    View in: PubMed
    Score: 0.102
  4. Emerging applications of gene transfer in the hematopoietic cancers. J Pediatr Hematol Oncol. 1997 Jan-Feb; 19(1):1-6.
    View in: PubMed
    Score: 0.102
  5. Gene marking. Hum Gene Ther. 1996 Oct 20; 7(16):1927-36.
    View in: PubMed
    Score: 0.101
  6. Transfer of marker genes into hemopoietic progenitor cells. Cytokines Mol Ther. 1996 Sep; 2(3):193-200.
    View in: PubMed
    Score: 0.100
  7. Gene transfer to hematopoietic cells. N Engl J Med. 1996 Aug 01; 335(5):337-9.
    View in: PubMed
    Score: 0.099
  8. The contribution of marker gene studies to hemopoietic stem cell therapies. Stem Cells. 1995 Sep; 13(5):453-61.
    View in: PubMed
    Score: 0.093
  9. The use of cytokines to improve gene transfer to human hematopoietic stem cells. Cytokines Mol Ther. 1995 Mar; 1(1):3-9.
    View in: PubMed
    Score: 0.090
  10. Gene transfer into human hemopoietic progenitor cells. Br Med Bull. 1995 Jan; 51(1):167-91.
    View in: PubMed
    Score: 0.089
  11. Current status of gene transfer into haemopoietic progenitor cells: application to Langerhans cell histiocytosis. Br J Cancer Suppl. 1994 Sep; 23:S56-7.
    View in: PubMed
    Score: 0.087
  12. Gene transfer into human hematopoietic progenitor cells: a review of current clinical protocols. J Hematother. 1993; 2(1):7-17.
    View in: PubMed
    Score: 0.078
  13. An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood. 1992 May 15; 79(10):2694-700.
    View in: PubMed
    Score: 0.074
  14. Inducible caspase 9 suicide gene to improve the safety of allodepleted T cells after haploidentical stem cell transplantation. Biol Blood Marrow Transplant. 2007 Aug; 13(8):913-24.
    View in: PubMed
    Score: 0.053
  15. Haematopoietic stem cell transplantation for autoimmune disease: limits and future potential. Best Pract Res Clin Haematol. 2004 Jun; 17(2):359-74.
    View in: PubMed
    Score: 0.043
  16. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A. 2003 Dec 23; 100(26):15877-82.
    View in: PubMed
    Score: 0.041
  17. Anti-CD45-mediated cytoreduction to facilitate allogeneic stem cell transplantation. Blood. 2003 Mar 15; 101(6):2434-9.
    View in: PubMed
    Score: 0.038
  18. Efficient infection of primitive hematopoietic stem cells by modified adenovirus. Gene Ther. 2001 Jun; 8(12):930-7.
    View in: PubMed
    Score: 0.035
  19. Gene transfer and the treatment of haematological malignancy. J Intern Med. 2001 Apr; 249(4):345-58.
    View in: PubMed
    Score: 0.034
  20. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3. Blood. 1999 Sep 15; 94(6):1906-14.
    View in: PubMed
    Score: 0.031
  21. Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med. 1999 Mar; 5(3):309-13.
    View in: PubMed
    Score: 0.030
  22. Fifth annual ISHAGE meeting - Oslo 1999. Cytotherapy. 1999; 1(3):163.
    View in: PubMed
    Score: 0.029
  23. Transduction of CD34(+) and CD34(-)/lin(-) hemopoietic progenitors by lentivirus vectors. Cytotherapy. 1999; 1(6):433-8.
    View in: PubMed
    Score: 0.029
  24. Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells. J Hematother. 1998 Jun; 7(3):217-24.
    View in: PubMed
    Score: 0.028
  25. Applications of gene transfer in hematologic malignancy. Recent Results Cancer Res. 1998; 144:60-9.
    View in: PubMed
    Score: 0.027
  26. Enhanced selectivity of hyperthermic purging of human progenitor cells using Goralatide, an inhibitor of cell cycle progression. Bone Marrow Transplant. 1998 Jan; 21(1):73-8.
    View in: PubMed
    Score: 0.027
  27. Hematological malignancies. FASEB J. 1997 Jul; 11(8):640-8.
    View in: PubMed
    Score: 0.026
  28. Mobilization of CD34+ progenitor cells by granulocyte colony-stimulating factor in human immunodeficiency virus type 1-infected adults. Blood. 1996 Nov 01; 88(9):3329-35.
    View in: PubMed
    Score: 0.025
  29. Gene transfer and therapeutic drug monitoring. Ther Drug Monit. 1996 Aug; 18(4):322-7.
    View in: PubMed
    Score: 0.025
  30. Human somatic gene therapy: progress and problems. J Intern Med. 1995 Mar; 237(3):229-39.
    View in: PubMed
    Score: 0.023
  31. Gene marking and autologous bone marrow transplantation. Ann N Y Acad Sci. 1994 May 31; 716:204-14; discussion 214-5, 225-7.
    View in: PubMed
    Score: 0.021
  32. Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission. Hum Gene Ther. 1994 Apr; 5(4):481-99.
    View in: PubMed
    Score: 0.021
  33. Gene transfer and bone marrow transplantation. Cold Spring Harb Symp Quant Biol. 1994; 59:691-7.
    View in: PubMed
    Score: 0.021
  34. Gene marking to improve the outcome of autologous bone marrow transplantation. Prog Clin Biol Res. 1994; 389:587-91.
    View in: PubMed
    Score: 0.021
  35. Tumor necrosis factor mediates autocrine growth inhibition in a chronic leukemia. J Immunol. 1989 Dec 01; 143(11):3828-34.
    View in: PubMed
    Score: 0.016
  36. Allorestricted cytotoxic T cells specific for human CD45 show potent antileukemic activity. Blood. 2003 Feb 01; 101(3):1007-14.
    View in: PubMed
    Score: 0.009
  37. Gene-marked autologous hematopoietic stem cell transplantation of autoimmune disease. J Clin Immunol. 2000 Jan; 20(1):1-9.
    View in: PubMed
    Score: 0.008
  38. Use of cell-free retroviral vector preparations for transduction of cells from the marrow of chronic phase and blast crisis chronic myelogenous leukemia patients and from normal individuals. Hum Gene Ther. 1992 Apr; 3(2):137-45.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.